ERBB2 and breast carcinoma: Triple negative breast cancer (TNBC) is a subgroup of breast cancer that is immunohistochemically characterized by the lack of estrogen receptor, progesterone receptor and HER2 (also defined by the lack of HER2 amplification [1].